Cargando…
Renoprotective effect of additional sodium–glucose cotransporter 2 inhibitor therapy in type 2 diabetes patients with rapid decline and preserved renal function
AIMS/INTRODUCTION: The slope of estimated glomerular filtration rate (eGFR) decline (eGFR slope) in early‐stage type 2 diabetes patients might predict the future risk of end‐stage renal disease. Type 2 diabetes patients who show rapid progressive eGFR decline are termed rapid decliners. Several stud...
Autores principales: | Sada, Kentaro, Hidaka, Shuji, Kashima, Jin, Morita, Machiko, Sada, Kokoro, Shibata, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340858/ https://www.ncbi.nlm.nih.gov/pubmed/35322583 http://dx.doi.org/10.1111/jdi.13795 |
Ejemplares similares
-
Clinical and genetic analysis in a family with familial renal glucosuria: Identification of an N101K mutation in the sodium–glucose cotransporter 2 encoded by a solute carrier family 5 member 2 gene
por: Sada, Kentaro, et al.
Publicado: (2019) -
The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors
por: Ito, Marie, et al.
Publicado: (2018) -
A case of polyneuropathy associated with diabetic ketoacidosis in new‐onset type 1 diabetes
por: Sada, Kokoro, et al.
Publicado: (2021) -
Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
por: Nakagaito, Masaki, et al.
Publicado: (2021) -
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
por: Kim, Nam Hoon, et al.
Publicado: (2022)